WallStreetZenWallStreetZen

NASDAQ: CTNM
Contineum Therapeutics Inc Stock Ownership - Who owns Contineum Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Contineum Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Daniel S. LorrainChief Scientific Officer2024-11-251,010$16.02
$16.18kSell
Daniel S. LorrainChief Scientific Officer2024-11-1899$17.05
$1.69kSell
Daniel S. LorrainChief Scientific Officer2024-11-186,091$16.37
$99.73kSell
Stephen L. HuhnCMO Sr VP Clinical Dev.2024-08-1312,800$1.01
$12.93kBuy

1 of 1

CTNM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CTNM insiders and whales buy or sell their stock.

CTNM Shareholders

What type of owners hold Contineum Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Johnson Johnson7.68%1,979,173$28.54MInstitution
Johnson Johnson7.68%1,979,173$28.54MInsider
Suvretta Capital Management LLC6.67%1,720,000$24.80MInstitution
Perceptive Advisors LLC5.88%1,516,668$21.87MInstitution
Franklin Resources Inc5.62%1,447,550$20.87MInstitution
Versant Venture Management LLC3.56%918,163$13.24MInstitution
Sectoral Asset Management Inc3.11%800,887$11.55MInstitution
Fmr LLC2.70%696,927$10.05MInstitution
Hhlr Advisors Ltd2.60%669,337$9.65MInstitution
Samsara Biocapital LLC2.28%588,816$8.49MInstitution

1 of 3

CTNM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CTNM52.75%10.47%Net BuyingNet Selling
SAGE69.77%30.23%Net Selling
ZBIO59.09%4.58%Net BuyingNet Buying
VYGR54.69%45.31%Net SellingNet Selling
XOMA18.16%81.84%Net SellingNet Selling
View Top Biotech Stocks

Contineum Therapeutics Stock Ownership FAQ

Who owns Contineum Therapeutics?

Contineum Therapeutics (NASDAQ: CTNM) is owned by 52.75% institutional shareholders, 10.47% Contineum Therapeutics insiders, and 36.78% retail investors. Johnson Johnson is the largest individual Contineum Therapeutics shareholder, owning 1.98M shares representing 7.68% of the company. Johnson Johnson's Contineum Therapeutics shares are currently valued at $28.20M.

If you're new to stock investing, here's how to buy Contineum Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.